| Home | << 1 2 3 4 5 6 7 >> |
|
Mellor, P. S. (1993). African horse sickness: transmission and epidemiology. Vet Res, 24(2), 199–212.
Abstract: African horse sickness (AHS) virus causes a non-contagious, infectious, arthropod-borne disease of equines and occasionally of dogs. The virus is widely distributed across sub-Saharan African where it is transmitted between susceptible vertebrate hosts by the vectors. These are usually considered to be species of Culicoides biting midges but mosquitoes and/or ticks may also be involved to a greater or lesser extent. Periodically the virus makes excursions beyond its sub-Saharan enzootic zones but until recently does not appear to have been able to maintain itself outside these areas for more than 2-3 consecutive years at most. This is probably due to a number of factors including the apparent absence of a long term vertebrate reservoir, the prevalence and seasonal incidence of the vectors and the efficiency of control measures (vaccination and vector abatement). The recent AHS epizootics in Iberia and N Africa spanning as they do, 5 or more yr, seem to have established a new pattern in AHS virus persistence. This is probably linked to the continuous presence of adult C imicola in the area. Culicoides imicola is basically an Afro-Asiatic insect and prefers warm climates. Therefore its continuous adult presence in parts of Iberia and N Africa may be due to some recent moderations of the climate in these areas.
Keywords: Africa, Northern/epidemiology; African Horse Sickness/epidemiology/*transmission; African horse sickness virus/*physiology; Animals; Arachnid Vectors/microbiology; Ceratopogonidae/*microbiology; Culicidae/microbiology; Horses; Insect Vectors/*microbiology; Portugal/epidemiology; Spain/epidemiology; Ticks/microbiology
|
|
Forbes, A. B. (1993). A review of regional and temporal use of avermectins in cattle and horses worldwide. Vet Parasitol, 48(1-4), 19–28.
Abstract: Ivermectin and abamectin are two members of the group of parasiticides known as the avermectins; ivermectin was first registered as an injectable treatment for cattle in 1981. Since then, abamectin has been registered for cattle and ivermectin for horses. The relative popularity of the avermectins amongst farmers and veterinarians can be attributed to their spectrum of activity, convenience, wide margin of safety and the improved health and performance of stock following their use. Patterns of use in grazing animals apply equally to the avermectins as to other antiparasitics, particularly anthelmintics; these are based on a knowledge of epidemiology integrated with practical management considerations. For cattle, programs are commonly aimed at control of abomasal nematodes of the genera Ostertagia and Haemonchus. Use of avermectins is largely strategic in cattle, treatments being favored at the end of the period of transmission of these parasites; this frequently coincides with housing, entry into a feedlot or movement to another pasture. Simultaneous control of important ectoparasites at this time is an added benefit. Prophylactic use of avermectins at pasture is primarily targeted at the young first season grazing animal. In horses, a bimonthly treatment schedule during the period of risk has proved effective in helping prevent adverse effects of the main target parasites, including large and small strongyles and stomach bots. These patterns of use can be applied to the evaluation of the potential for avermectin residues in feces to have impact on pasture ecology. The evidence presented suggests that any effects are temporally and spatially limited. After more than a decade of practical use, there is no indication that avermectins have had a significant impact on pasture ecology and the environment.
Keywords: Animals; Anthelmintics/therapeutic use; Arthropods; Cattle; Cattle Diseases/drug therapy/*prevention & control; Ectoparasitic Infestations/drug therapy/prevention & control/veterinary; Horse Diseases/drug therapy/*prevention & control; Horses; Insecticides; Ivermectin/*analogs & derivatives/*therapeutic use; Nematode Infections/drug therapy/prevention & control/veterinary; Parasitic Diseases/drug therapy/prevention & control; *Parasitic Diseases, Animal
|
|
Argue, C. K., & Clayton, H. M. (1993). A preliminary study of transitions between the walk and trot in dressage horses. Acta Anat (Basel), 146(2-3), 179–182.
Abstract: The object of this study was to determine the limb support sequence during the transitions from walk to trot and from trot to walk in dressage horses under saddle and to test the null hypothesis that the limb support sequence during the transitions is not related to the level of training. Sixteen dressage horses training at novice to FEI Grand Prix level were videotaped performing an average of 9 transitions each from walk to trot and from trot to walk. The 30-Hz videotapes were viewed in slow motion, and based on the limb support sequence the transitions were categorized into two types. In type 1 transitions there were no intermediate steps between the walk and trot sequences. Type 2 transitions were characterized by intermediate steps, including a single support phase. The Kendall rank-order correlation coefficient showed that a higher level of training was positively associated with an increased percentage of type 1 transitions for both walk-to-trot transitions (p < or = 0.05) and trot-to-walk transitions (p < or = 0.01). No significant preference for initiating or completing the trot on the left or right diagonal was found using the binomial test for individual horses and the Wilcoxon signed-ranks test for the group.
|
|
Lieberman, D. (1993).
|
|
Parelli, P. (1993).
|